2025
SJR Q1
JCR Q1 · 5
38 matched articles
SCIE
Journal detail
Hypertension Research
- Publisher
- Springer Nature
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
0916963613484214
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,355
- Quartile Q1
- H-Index 113
- Cites/doc 3,34
- Docs (3y) 1.125
- Cites (3y) 3.625
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 5
- 5Y JIF 4,4
- JCI 1,01
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cardiology and Cardiovascular Medicine Q1
- Internal Medicine Q1
- Physiology Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Peripheral Vascular Diseases
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,355 | 5 | 4,4 | 1,01 | Q1 | 113 |
| 2024 | Q1 | Q1 | 1,071 | 4,6 | 4,3 | 1,09 | Q1 | 107 |
| 2023 | Q2 | Q1 | 0,934 | 4,3 | 4 | 0,93 | Q1 | 107 |
| 2022 | Q1 | Q1 | 0,998 | 5,4 | 4,8 | 0,84 | Q1 | 107 |
| 2021 | Q1 | Q2 | 1,119 | 5,5 | 4,4 | 0,79 | Q2 | 107 |
| 2020 | Q1 | Q2 | 1,022 | 3,9 | 3,6 | 0,79 | Q2 | 107 |
| 2019 | Q2 | Q2 | 0,885 | 2,9 | 2,8 | 0,74 | Q2 | 107 |
| 2018 | — | Q2 | — | 3,2 | 2,8 | 0,85 | Q1 | — |
| 2017 | Q1 | Q1 | 1,411 | 3,4 | 3 | 0,78 | Q2 | 107 |
| 2016 | Q1 | Q2 | 1,383 | 3,6 | 3 | — | — | 107 |
| 2015 | Q1 | Q2 | 1,38 | 3,2 | 2,7 | — | — | 107 |
| 2014 | Q1 | Q2 | 1,051 | 2,7 | 2,6 | — | — | 107 |
| 2013 | Q1 | Q2 | 1,208 | 2,9 | 2,7 | — | — | 107 |
| 2012 | Q1 | Q2 | 1,175 | 2,8 | 2,7 | — | — | 107 |
| 2011 | Q1 | Q2 | 0,762 | 2,6 | 2,4 | — | — | 107 |
| 2010 | Q1 | Q2 | 0,74 | 2,4 | 2,5 | — | — | 107 |
| 2009 | — | Q2 | — | 2,4 | 2,7 | — | — | — |
| 2008 | — | Q2 | — | 3,1 | 3,2 | — | — | — |
| 2007 | — | Q2 | — | 3 | 2,8 | — | — | — |
| 2006 | — | Q2 | — | 3,2 | — | — | — | — |
| 2005 | — | Q2 | — | 2,8 | — | — | — | — |
| 2004 | — | Q3 | — | 1,7 | — | — | — | — |
| 2003 | — | Q2 | — | 2 | — | — | — | — |
| 2002 | — | Q2 | — | 2 | — | — | — | — |
| 2001 | — | Q2 | — | 1,9 | — | — | — | — |
| 2000 | — | Q2 | — | 2,1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 21/100 |
| 2024 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 16/98 |
| 2023 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 15/96 |
| 2022 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 17/68 |
| 2021 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 18/67 |
| 2020 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 23/65 |
| 2019 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 25/65 |
| 2018 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q1 | 22/65 |
| 2017 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q2 | 16/65 |
| 2016 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 16/63 |
| 2015 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 19/63 |
| 2014 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 30/60 |
| 2013 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 26/65 |
| 2012 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 28/68 |
| 2011 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 28/68 |
| 2010 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 31/68 |
| 2009 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 26/61 |
| 2008 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 18/56 |
| 2007 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 20/54 |
| 2006 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 16/52 |
| 2005 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 19/51 |
| 2004 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 27/51 |
| 2003 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 21/52 |
| 2002 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 21/52 |
| 2001 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 23/50 |
| 2000 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 20/45 |